Kevin Schultz is a seasoned professional in the pharmaceutical industry with extensive experience in sales and marketing. Currently serving as Senior Director of Sales & Marketing at Gilead Sciences since 2012, Kevin is a key member of the Canadian executive team, leading the HIV/AIDS business and overseeing the successful launch of seven new antiretrovirals, including Biktarvy, the top-prescribed antiretroviral in Canada. Previously, Kevin held various leadership roles at AstraZeneca, including Director of Marketing for multiple divisions with significant revenue responsibilities and Senior Marketing Manager for the Neuroscience/Respiratory portfolio. Early career experience includes serving as Group Product Manager at Boehringer Ingelheim Canada, focusing on the Respiratory and Urology portfolios. Kevin holds a Bachelor of Commerce degree in Marketing & Finance from Dalhousie University.
This person is not in any teams
This person is not in any offices